Normal view MARC view ISBD view

Simian immunodeficiency virus disrupts extended lengths of the blood--brain barrier. [electronic resource]

By:

Maclean, A G

Contributor(s):

Producer: 20051227Description: 237-42 p. digitalISSN:

0047-2565

Subject(s):

Online resources:

Available from publisher's website

In: Journal of medical primatology vol. 34

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comparative Study; Journal Article

There are no comments on this title.

to post a comment.

Back to results

2921 [Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].
by Fournier-Del Castillo, M Concepción
2922 Guidelines for severe uncontrolled asthma.
by Cisneros Serrano, Carolina
2923 Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.
by Watanabe, Norio
2924 Legal, ethical, and economic implications of breaking down once-daily fixed-dose antiretroviral combinations into their single components for cost reduction.
by Ramiro, Miguel A
2925 Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study.
by Liu, Dai-hong
2926 Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial).
by Ning, Qin
2927 Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
by Teter, Barbara
2928 Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
by Alves, Marcelle D
2929 [A specific questionnaire to evaluate therapeutic inertia in hypertensive patients: a pilot study].
by Pretorean, T
2930 Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
by Kook, Michael Scott
2931 Survey of the National Drug Shortage Effect on Anesthesia and Patient Safety: A Patient Perspective.
by Hsia, Ivan Kai-Hsiang
2932 Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
by Essebag, Vidal
2933 Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
by Brennan, Emily T
2934 None
by Muheim, Leander
2935 Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy.
by Barbari, Antoine
2936 Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.
by Holdaas, Hallvard
2937 Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor.
by Yamamoto, Keiko
2938 Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
by Belhassen, M
2939 Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.
by Ogawa, Miho
2940 Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis.
by Codreanu, Cătălin